Back to Trades
Sell4
GILEAD SCIENCES, INC.
GILD
Total Value
$7.7M
Net $4.3M sold
Sales
$4.3M
3 transactions
Company Information
- Company Name
- GILEAD SCIENCES, INC.
- Ticker Symbol
- GILD
- CIK
- 0000882095
Insider Information
- Name
- Mercier Johanna
- Role
- Chief Comm & Corp Aff Officer
- Location
- FOSTER CITY, CA
Officer
Filing Details
- Filing Date
- Feb 18, 2026
- Transaction Date
- Feb 17, 2026
- Accession Number
- 0001782135-26-000006
- Form Type
- 4
- Net Trading Amount
- -$4.3M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | 25,000 | $66.64 | Exercise | $1.7M |
| Feb 17, 2026 | Common Stock | 18,405 | $154.18 | Sale | $2.8M |
| Feb 17, 2026 | Common Stock | 9,395 | $154.91 | Sale | $1.5M |
| Feb 17, 2026 | Common Stock | 200 | $155.62 | Sale | $31.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Derivative | 25,000 | $66.64 | Exercise | $1.7M |
Footnotes
- (F1)The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- (F2)Sale prices for the transactions reported range from $153.565 to $154.56 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- (F3)Sale prices for the transactions reported range from $154.57 to $155.27 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- (F4)The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.